Sentence examples for formulations containing an from inspiring English sources

The relative increase in the risk of ischemic stroke with the use of combined oral formulations containing an ethinylestradiol dose between 20 and 40 μg is about 2-fold [25, 74].

28 A second approach is the use of formulations containing an inhaled corticosteroid and a long acting β agonist.

For all formulations containing an equal ratio of azide to cyclooctyne functionality, we estimate the degree of network ideality (i.e., extent of cross-linking versus cyclization) to be >90% (derivations and results for all formulations are given in the see the Supporting Information, Table S1).

Formulations containing a polymer, a lipid and two different silica based inorganic carriers were produced by hot-melt extrusion.

The formulations containing a polymer-to-drug ratio of 6 1 were amorphous and showed superior pH dependent in vitro drug release performance.

The results revealed that the formulations containing a high proportion of furfuryl alcohol, a moderate proportion of tannin and a low level of catalyst led to the best compromise between properties having opposed trends.

In vitro release studies demonstrated that there were no initial burst of pGH from both formulations containing a low dose (0.12%, w/v) and a high dose (0.42%, w/v) of pGH.

The use of pregelatinised starch in tamp filling of hard capsules with powder formulations containing a low-solubility drug (theophylline anhydrous) with very poor powder flow and stickiness to metal surfaces was investigated.

Formulations containing a mixture of medium-chain triglycerides and soybean oil as oil phase, lecithin (soybean/egg) and polysorbate 80 as emulsifiers, and 0.1 M phosphate buffer solution (pH 8) as aqueous phase were prepared by cold high-pressure homogenization.

As per protocol, formulations containing a nominal 185 MBq of I-124 codrituzumab, 10 mg of codrituzumab, and 5 mL of 0.9% sodium chloride containing 5% human serum albumin were used.

Expanding on the beneficial effects of MPL®, we have developed a series of formulations containing a synthetic molecule called Glucopyranosyl Lipid A (GLA), which is optimized for binding to the human MD2 molecule of the TLR4 complex.